logo

GKSL vs ZOTA: Stock Comparison

GUJARAT KIDNEY N SUP SP L vs ZOTA HEALTH CAREUpdated 19 Oct 26, 4:08 PM ISTNSE & company filings

ZOTA HEALTH CARE is the larger company by market capitalisation. GUJARAT KIDNEY N SUP SP L shows a higher ROE, a higher ROCE and a higher net margin, while ZOTA HEALTH CARE shows a lower P/E, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GKSL leads 6; ZOTA leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GKSLZOTA

Valuation lens

What price are you paying?

Market CapContext only
₹1,487 Cr
₹4,714 Cr
P/E RatioZOTA has the lower reading
93.81x
0x ✓
P/B RatioGKSL has the lower reading
5.89x ✓
6.8x
EPSGKSL has the higher reading
₹0.66 ✓
₹-12.58
Book ValueContext only
₹32.31
₹201.01
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ZOTA is the larger company
₹4,714 Cr vs ₹1,487 Cr
P/E Ratio
ZOTA has a lower P/E
0x vs 93.81x
P/B Ratio
GKSL has a lower P/B
5.89x vs 6.8x
EPS
GKSL has higher earnings per share
₹0.66 vs ₹-12.58
Revenue Growth (TTM YoY)
ZOTA has faster revenue growth
67.7% vs 0%
ROE
GKSL has a higher ROE
7.58% vs -10.64%
ROCE
GKSL has a higher ROCE
8.56% vs -8.71%
Net Margin
GKSL has a higher net margin
20.5% vs -13.98%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGKSLZOTA
Sector—Healthcare
Industry—Pharmaceuticals

Price

MetricGKSLZOTA
Live Price₹187.76₹1,359.9
Day Change0.21%-3.51%
Volume4.35 L44,643
52-Week High₹209.8₹1,740
52-Week Low₹98.36₹1,022
Distance from 52W High-10.51%-21.84%

Valuation

MetricGKSLZOTA
Market Cap₹1,487 Cr₹4,714 Cr
P/E Ratio93.81x0x
P/B Ratio5.89x6.8x
EPS₹0.66₹-12.58
Book Value₹32.31₹201.01
Dividend Yield0%0%

Growth

MetricGKSLZOTA
Revenue Growth (TTM YoY)0%67.7%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricGKSLZOTA
ROE7.58%-10.64%
ROCE8.56%-8.71%
Net Margin20.5%-13.98%
Operating Margin18%-11.6%
Debt to Equity0.06x0.04x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricGKSLZOTA
Promoter Holding71.45%49.38%
FII Holding6.53%▲ 1.65 pp7.92%▼ 0.29 pp
DII Holding0.26%▼ 0.3 pp6.75%▲ 0.35 pp
Public Holding21.77%▼ 1.33 pp35.96%▼ 0.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GUJARAT KIDNEY N SUP SP L and ZOTA HEALTH CARE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.